| 1. |
Kaplan HI, Sadock BJ. Tratado de Psiquiatria 2ª
ed. Barcelona: Masson-Salvat; 1989. |
| 2. |
Frances A, First MP, Pincus HA. DSM-IV, Guía de uso.
Barcelona: Masson; 1997. |
| 3. |
Sazman L, Thaler FH. Obsessive-compulsive disorder: a review of the
literature. Am J Psychiatry 1981;138:286-96. |
| 4. |
Menchón JM. Espectro y trastorno obsesivo compulsivo.
Psiquiatr Biol1997;4(5):175-6. |
| 5. |
Karno M, Golding J, Sorenson S, Burmam M. The epidemiology of
obsessive compulsive disorder in five U.S. communities. Arch Gen
Psychiatry 1988;45:1094-9. |
| 6. |
López-Ibor JJ. Intravenous perfusion of monochlorimipramine.
Techniques and results. En: Proceedings of the International College of
CINP; 1968 Apr (Int Congress Series. 180. 519); Teragone. The
Netherlands: Excerpta Medica; 1969. |
| 7. |
McDougle CJ, Goodman WK, Price LH. New research on the neurobiology
of obsessive-compulsive disorder. Current Opinion Psychiatry 1992;5:
249-54. |
| 8. |
Fernández de Córdoba E, López-Ibor JJ.
Monochlorimipramine en el tratamiento de pacientes psiquiatricos
resistentes a otras terapias. Actas Luso Esp Neuro Psiquiatr Cienc
Afines 1967;26:119-47. |
| 9. |
Marks IM, Stern RS, Mawson D, Cobb J, McDonald R. Clomipramine and
exposure for obsesive and compulsive rituals: Br J Psychiatry
1980;136:1-25. |
| 10. |
DeVeaugh Geiss J, Landau P, Katz R. Treatment of obsessive and
compulsive disorder with clomipramine. Psychiatr Ann 1989;19:97. |
| 11. |
Clomipramine Collaborative Study Group. Clomipramine in the
treaatment of patients with obssesive compulsive disorder. Arch Gen
Psychiatry 1991;48:730-8. |
| 12. |
Marks I, O´Sullivan G. Drugs and Psichobiological treatments
for agorafobia\panic and obsessive-compulsive disorders. A review. Br J
Psychiatry 1988;153:650-8. |
| 13. |
Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón J.
Clomipramine versus phenelzine in obsessive compulsive disorder. A
controled clinical trial. Br J Psychiatry 1991;161:665-70. |
| 14. |
Hellewtt W, Vinogradov S, Agras S. Clomipramine, clonazepam, and
clonidine treatment in obsessive compulsive disorder. J Clin
Psychopharmacol 1992;12:420-30. |
| 15. |
Jenike JA, Baer L, Summergrad P, Weilburg JB, Holland A, Seymour R.
Obsessive-compulsive disorder: A double blind, placebo-controled trial
of clomipramine in 27 patients. Am J Psychiatry 1989;146:1328-30. |
| 16. |
Den Boer, J.A.Psicofarmacología del trastorno obsesivo
compulsivo y la depresión concurrentes. J Clin Psychiatry 1997;58
(Supl 8):17-9. |
| 17. |
Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L.
Clomipramine treatment in the obsessive compulsive disorder. A controled
clinical trial. Arch Gen Psychiatry 1980;37:1281-5. |
| 18. |
Volavska J, Neziroglu F, Yaryura-Tobias J. Clomipramine and
imipramine in obsessive-compulsive disorder. Psychiatr Res
1985;14:83-91. |
| 19. |
Pato PT, Zohar-Kadouch RC, Zohar J, Murphy DL. Return of sintomps
after discontinuation of clomipramine in patients with obsessive
compulsive disorder. Am J Psychiatry 1988;145:1521-5. |
| 20. |
Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. Drug treatment
of Obsessive Compulsive Disorder: Long-term Trial with Clomipramine and
selective serotonin reuptake inhibitors. Psychopharmacol Bull
1996;32(1):167-73. |
| 21. |
Wyant Jackson C. Morton WA, Lydiard RB. Pharmacologic management of
obsessive compulsive disorder. Southern Med J 1994;87:310-21. |
| 22. |
Insel T, Hamilton J, Guttmacher L, Murphy D. Obsessive-compulsive
disorder and serotonin: Is there a connection? Biol Psychiatry
1985;20:231-5. |
| 23. |
Zohar J, Zohar-Kadouch RC, Kindler S. Current concepts in the
pharmacological treatment of obsessive-compulsive disorder. Drugs
1992;43:210-8. |
| 24. |
Ananth J, Pecknold JC, Steen N, van den&Engelsmann F.
Double-blind comparative study of clomipramine and amitriptyline in
obsessive neurosis. Progress Neuro-Psychopharmacol 1981;5:257-62. |
| 25. |
Dolberg OT, Iancu I, et al. Pharmacotherapy of obsessive-compulsive
disorder. En: Den Boer JA, Westenberg editores. Focus on Obsessive
compulsive Spectrum Disorder. H.G.M.: 1997. Chap. 8, p. 140. |
| 26. |
Jenike MA, Buttolph L, Baer L, Ricciardi J, Holland A. Open trial
of Fluoxetine in obssesive compulsive disorder. Am J Psychiatry
1989;146:909-11. |
| 27. |
Liebowitz MR, Hollander E, Schneier F, Campeas R, Hatterer J,
Papp-L, et al. Fluoxetine treatment of obssesive compulsive disorder: an
open trial. J Clin Psychopharmacol 1989;9:423-7. |
| 28. |
Montgomery SA, et al. A double-blind, placebo controlled study of
fluoxetine in patients with obsessive compulsive disorder. The Lilly
European Study Group. Eur Neuropsychopharmacol 1993;3:143-52. |
| 29. |
Toffelson GD, Rampey AH, Potvin JH. A multicenter investigation of
fixed-dose fluoxetine in the treatment of obsessive compulsive disorder.
Arch Gen Psychiatry1994;51:559-67. |
| 30. |
Pigott T, Pato M, Berstein S. Controlled comparisons of
clomipramine and fluoxetine in the treatment of obsessive and compulsive
disorder. Arch Gen Psychiatry 1990;47:926-32. |
| 31. |
López-Ibor JJ, Saiz J, Cottraux J, Note I, Vinas R,
Bourgeois M, et al. Double-blind comparison of fluoxetine versus
clomipramine in the treatment of obsessive compulsive disorder. Eur
Neuropsychopharmacol 1996;6(2):111-8. |
| 32. |
Saiz J, López-Ibor JJ, Cottreau J, et al. Double-blind
comparison of fluoxetine and clomipramine in obsessive-compulsive
disorder. Eur Neuropsychopharmacol 1992;2(3):204-5. |
| 33. |
Goodman WK, Price LH, Rasmunsen SA. Eficacy of fluvoxamine in
obsessive compulsive disorder. A double-blind comparison. Arch Gen
Psychiatry 1989;46:36-40. |
| 34. |
Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L,
et al. A controled trial of fluvoxamine in obsessive compulsive
disorder. Am J Psychiatry 1990;147:1209-15. |
| 35. |
Goodman WK, Kozak MJ, Liebowitz M, White KL. Treatment of obsessive
compulsive disorder with fluvoxamine: a multicentre double-blind. Int
Clin Psychopharmacol 1996 Mar;11(1):21-9. |
| 36. |
Dolberg OT, Iancu I, Sasson Y, Zohar Y. The pathogenesis and
treatment of Obsessive-Compulsive disorder. Clin Neuropharmacology
1996;2:129-47. |
| 37. |
Goodman WK, Ward H, Kablinger A, Murphy T. Fluvoxamine in the
treatment of obsessive-compulsive disorder and related conditions. J
Clin Psychiatry 1997;58 (Suppl 5):32-49. |
| 38. |
Greist J, Chouinard G, DuBoff E, et al. Long-term sertraline
treatment of obsessive compulsive disorder: A 52-week double-blind
comparative study versus placebo. En: 9Th Wordl Congress of Psychiatry;
1993 Jun;Rio de Janeiro, Brazil. p. 20-1. |
| 39. |
Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM,
et al. Specifity of serotonine reuptake inhibitors in the treatment of
obsessive compulsive disorder. Comparison of Fluvoxamine and
desipramine. Arch Gen Psychiatry 1990;47:577-85. |
| 40. |
Milanfranchi A, et al. A double blind study of fluvoxamine and
clomipraminein the treatment of bsessive-compulsive disorder. Int Clin
Psychopharmacol 1997 May;12(3):131-6. |
| 41. |
Freeman CPL, Trimble MR, Deakin JFW, Stokes TM, Ashford JJ, et al.
Fluvoxamine versus clomipramine in the treatment of OCD: A multicentre,
randomised, double blind, paralell group comparison. J Clin
Psychiatry1994;55:301-5. |
| 42. |
Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K,
et al. Results of a double-blind placebo controlled trial of sertraline,
in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull
1990,26:279-84. |
| 43. |
Greist J, Chouinard G, DuBoff E. Double-blind comparison of three
doses of sertraline and placebo in the treatment of obsessive compulsive
disorder. Arch Gen Psychiatry 1995;52(2):289-95. |
| 44. |
Greist J, Chouinard G, et al. Long-term sertraline treatment of
obsessive compulsive disorder.: A 52-week double blind comparative study
versus placebo. En: 9th World Congress of Psychiatry; 1993 Jun; Rio de
Janeiro, Brazil; 1993. p. 20-1. |
| 45. |
Kronig M, Apter J, Asnis G, et al. A multicenter trial of
sertraline for obsessive-compulsive disorder. Poster presented at the
33rd annual meeting of the American College of Neuropharmacology; 1994
Dec; San Juan, Puerto Rico. p. 12-6. |
| 46. |
Bisserbe JC, Wisseman R, Goldberg M, Lane R. A double-blind
comparison of sertraline and clomipramine in outpatients with
obsessive-compulsive disorder. Poster presented at the 148th annual
meeting of the American Psychiatric Association; 1995 May; Miami, USA.
p. 20-5 . |
| 47. |
Wheadon DE, Bushnell WD, Steiner M. Paroxetine versus placebo in
obsessive-compulsive disorder. Am J Psychiatry 1995. |
| 48. |
Wheadon DE, Gergel IP. Long-term treatment with paroxetine of
patients with Obsessive and Compulsive Disorder. An extension of three
fixed dose study. J Clin Psichiatry 1995. |
| 49. |
Murray MG, Newman RM. Paroxetine for treatment of obsessive
compulsive disorder and comorbid stuttering [letter]. Am J Psychiatry
1997 Jul;154(7):1037. |
| 50. |
Mundo E, Bianchi L, Bellodi L. Efficacy of fluvoxamine, paroxetine,
and citalopram in the treatment of obsessive-compulsive disorder: a
single-blind study. J Clin Psychopharmacol 1997 Aug;17(4):267-71. |
| 51. |
Zohar J, Judge R. Paroxetine versus clomipramine in the treatment
of obsessive-compulsive disorder. Br J Psychiatry 1996;169:468-74. |
| 52. |
Vallejo J, Pifarré J. Tratamientos farmacológicos del
trastorno obsesivo-compulsivo. Psicofarmacología 1998;2:21-33. |
| 53. |
Brawman-Mintzer O, Lydiard RB. Psychopharmacology of anxiety
disorders. Psychiatr Clin North Am 1994;1:51-79. |
| 54. |
Hyttel J. Pharmacological characterization of selective serotonin
reuptake inhibitors. International Clinical Psychopharmacol
1994;9S:19-26. |
| 55. |
Montgomey SA, Pedersen V, Tanghj P, Rasmussen C, Rioux P, et al.
The optimal dosing regime for citalopram-a meta-analysis of nine
placebo-controlled studies. Int Clin Psychopharmacol 1994;9S:35-40. |
| 56. |
Bejerot S, Humble M. Citalopram treatment of obssesive-compulsive
disorder: A pilot study of antiobssesive eficacy. Biol Psychiatry
1991;29:443. |
| 57. |
Stein DJ, Maud CM, Bouwer C. Use of the serotonin selective
reuptake inhibitor citalopram in obsessive compulsive disorder. J
Serotonin Research 1996;1:29-33. |
| 58. |
Vallejo J. Tratamientos Biológicos. En: Vallejo J, director.
Estados Obsesivos. 2ª ed. Barcelona: Masson; 1995. p. 387-8. |
| 59. |
Vallejo J, Olivares J, Marcos T, Bulbena A, Menchon JM.
Clomipramine versus phenelzine in obssesive compulsive disorder: A
controled clinical trial. Br J Psychiatry 1992;161:665-70. |
| 60. |
Jenike MA, Baer L, Minichiello WE, Rauch SL, Buttolph ML.
Placebo-controled trial of Fluoxetine and Phenelzine for
Obsessive-Compulsive disorder. Am J Psychiatry 1997;154:1261-4. |
| 61. |
Toffelson G. Alprazolam in the obssesive compulsive disorder. J
Clin Psychopharmacol 1985;5:39-42. |
| 62. |
Hewlett WA, Vinagradov S, Agras WS. Clomipramine, clonazepam and
clonidine treatment of obssesive-compulsive disorder. J Clinic
Psychopharmacol 1992;12:420-30. |
| 63. |
Harvey KV, Balon R. Augmentation with buspirone: a review. Ann Clin
Psychiatry 1995 Set;7(3):143-7. |
| 64. |
Mcdougle Ch, Goodman W, Price LH, Delgado PL, Krystal JH, Charney
DS, et al. Neuroleptic addition in fluvoxamine-refractary obsessive
compulsive disorder. Am J Psychiatry 1990;147:652-4. |
| 65. |
McDougle Ch, Goodman W, Leckman JF, Lee NC, Heninger GR, Price LH.
Haloperidol addition in fluvoxamine refractory obssesive compulsive
disorder. Arch Gen Psychiatry 1994;51:302-8. |
| 66. |
Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellstrom B,
et al. Clomipramine treatment of childhood obsessive-compulsive
disorder. A double-blind controlled study. Arch Gen Psychiatry
1985;42:977-83. |
| 67. |
Leonard HL, Swedo SE, Lenane MC, Rettew DC, Hamburger SD, Bartko
JJ, et al. A 2-to7-year follow-up study of 54 obssesive compulsive
children and adolescents. Arch Gen Psychiatry 1993;50:429-39. |
| 68. |
Rosenberg DR, Holttum J, Gershon S. Textbook of pharmacotherapy for
child and adolescent psychiatric disorders. New York: Bruner/Mazel;
1994. |
| 69. |
Apter A, Ratzoni G, King RA, Weizman A, Iancu I, Binder M, et al.
Fluvoxamine open label treatment of adolescent inpatients with obssesive
compulsive disorder or depression. J Am Acad Child Adolesc
Psychiatry1994;33(3):342-8. |
| 70. |
Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort-SI, et
al. Double-blind cross-over trial of fluoxetine and placebo in children
and adolescents with obssesive compulsive disorder. J Am Acad Child
Adolesc Psychiatry 1992;31(6):1062-9. |
| 71. |
Vallejo J. Tratamiento de los trastornos obsesivos compulsivos. En:
Vallejo J, director. Arboles de decisión en psiquiatría.
Barcelona: JIMS; 1992. p. 78-9. |
| 72. |
March JS, Frances A, et al. The expert Consensus Guideline Series.
Treatment of Obsessive-compulsive disorder. J Clin Psychiatry 1997;58
(Suppl 4). |